Trials / Completed
CompletedNCT01251302
Utility of a Molecular Personalized Coronary Gene Expression Test (Corus CAD or ASGES) on Cardiology Practice Pattern
Investigation of a Molecular Personalized Coronary Gene Expression Test on Cardiology Practice Pattern
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 171 (actual)
- Sponsor
- CardioDx · Industry
- Sex
- All
- Age
- 21 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
To investigate whether the use of Corus CAD (Age/Sex/Gene Expression score - ASGES) blood assay changes the diagnostic testing pattern in patients referred to a cardiologist for the evaluation of chest pain or anginal equivalent symptoms.
Detailed description
A prospective cohort of 88 subjects receiving the Corus CAD (Age/Sex/Gene Expression score - ASGES) assay were compared to a retrospective cohort of 83 subjects that did not receive the assay.
Conditions
- Angina Pectoris
- Coronary Artery Disease
- Chest Pain
- Cardiovascular Diseases
- Coronary Heart Disease
- CAD
- CVD
- CHD
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Corus CAD (ASGES) | Age/Sex/Gene Expression Score - ASGES |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2012-02-01
- Completion
- 2012-06-01
- First posted
- 2010-12-01
- Last updated
- 2019-01-31
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01251302. Inclusion in this directory is not an endorsement.